Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderate-to-severe Inflammatory Bowel Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01959282
What this trial is testing

Safety and Effectiveness of JNJ-54781532 in Patients With Moderately to Severely Active Ulcerative Colitis

Who this might be right for
Colitis, Ulcerative
Janssen Research & Development, LLC 219
Testing effectiveness (Phase 2)Ended earlyNCT05156125
What this trial is testing

VTX002 Versus Placebo for the Treatment of Moderately to Severely Active Ulcerative Colitis

Who this might be right for
Colitis, Ulcerative
Oppilan Pharma Ltd 213
Post-approval studies (Phase 4)Study completedNCT01941589
What this trial is testing

Corticosteroids+5-aminosalicylic Acid Compared to Corticosteroids in the Treatment of Moderate-severe Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
Sheba Medical Center 149
Large-scale testing (Phase 3)Ended earlyNCT02144350
What this trial is testing

Hyperbaric Oxygen for Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
Dartmouth-Hitchcock Medical Center 18
Large-scale testing (Phase 3)Active Not RecruitingNCT05528510
What this trial is testing

Guselkumab Therapy in Participants With Moderately to Severely Active Ulcerative Colitis

Who this might be right for
Colitis, Ulcerative
Janssen Research & Development, LLC 418
Large-scale testing (Phase 3)UnknownNCT01790061
What this trial is testing

Standardized Fecal Microbiota Transplantation for Ulcerative Colitis

Who this might be right for
BacteriaMicrobiotaFecal Microbiota Transplantation+2 more
The Second Hospital of Nanjing Medical University 500
Large-scale testing (Phase 3)Study completedNCT00783718
What this trial is testing

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
Millennium Pharmaceuticals, Inc. 895
Large-scale testing (Phase 3)Study completedNCT00102193
What this trial is testing

Study for the Treatment of Ulcerative Colitis With Adacolumn

Who this might be right for
Ulcerative Colitis
Otsuka America Pharmaceutical 168
Not applicableLooking for participantsNCT07136116
What this trial is testing

Study to Assess Change in Disease Activity of Risankizumab Treatment in Japanese Participants With Moderate to Severe Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
AbbVie 200
Large-scale testing (Phase 3)Study completedNCT00207662
What this trial is testing

A Safety and Efficacy Study of Infliximab (Remicade) in Patients With Moderate to Severe Active Crohn's Disease

Who this might be right for
Crohn Disease
Centocor, Inc. 580
Large-scale testing (Phase 3)Ended earlyNCT03566823
What this trial is testing

Efficacy and Safety Study of Ontamalimab as Induction Therapy in Participants With Moderate to Severe Crohn's Disease (CARMEN CD 306)

Who this might be right for
Crohn's Disease
Shire 34
Testing effectiveness (Phase 2)Active Not RecruitingNCT06254950
What this trial is testing

A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
Takeda 213
Large-scale testing (Phase 3)Looking for participantsNCT06059989
What this trial is testing

InDuctIon TREatment with SubCuTaneous Infliximab for Crohn's Disease

Who this might be right for
Inflammatory DiseaseDisease CrohnBowel Disease
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 158
Not applicableStudy completedNCT03142113
What this trial is testing

Clinical Outcome After Escalation and De-escalation of Adalimumab in Real Life in Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
Universitaire Ziekenhuizen KU Leuven 231
Early research (Phase 1)Looking for participantsNCT07758101
What this trial is testing

Evaluate the Safety of SHR-7590 in Chinese Healthy Participants and in Patients With Moderate-to-severe Inflammatory Bowel Disease

Who this might be right for
Moderate-to-severe Inflammatory Bowel Disease
Guangdong Hengrui Pharmaceutical Co., Ltd 88
Not applicableLooking for participantsNCT06838845
What this trial is testing

An Observational Study to Evaluate Effectiveness and Safety of Upadacitinib in Chinese Adult Participants With Moderate to Severely Active Ulcerative Colitis (UC)

Who this might be right for
Ulcerative Colitis
AbbVie 80
Large-scale testing (Phase 3)Study completedNCT03234907
What this trial is testing

Vedolizumab Intravenous (IV) Compared to Placebo in Chinese Participants With Crohn's Disease.

Who this might be right for
Crohn's Disease
Takeda 215
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07677514
What this trial is testing

A Phase II Study of H021 Enteric-coated Tablets for Moderately to Severely Active Crohn's Disease

Who this might be right for
Crohn's Disease
Jiangsu Carephar Pharmaceutical Co., Ltd. 156
Post-approval studies (Phase 4)Looking for participantsNCT06095128
What this trial is testing

Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)

Who this might be right for
Ulcerative Colitis
Takeda 60
Large-scale testing (Phase 3)Looking for participantsNCT06332534
What this trial is testing

Crohn's Disease: Efficacy, Safety, and Pharmacokinetics of Upadacitinib in Pediatric Subjects With Moderately to Severely Active Crohn's Disease

Who this might be right for
Crohn's Disease
AbbVie 110
Next Page